Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
6
×
detroit blog main
detroit top stories
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
6
×
pfizer
6
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
6
×
amgen
deals
alexion pharmaceuticals
celgene
eli lilly
investing
ipo
medicare
merck
roche
What
bio
roundup
drug
gene
latest
life
millions
moves
new
patients
pharmaceutical
plan
science
typically
acquisitions
advantages
alzheimer’s
american
annual
ash
bails
bar
becker
biggest
billions
blood
borne
brand
bridgebio
brings
build
buy
cancers
capital
car
ceo
companies
company’s
conference
daniel
Language
unset
Current search:
pfizer
×
novartis
×
" wisconsin top stories "
×
" detroit top stories "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More